Literature DB >> 30579917

"Disease knowledge index" and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases.

Laura Andreoli1, Maria Grazia Lazzaroni2, Chiara Carini3, Francesca Dall'Ara1, Cecilia Nalli1, Rossella Reggia1, Marília Rodrigues4, Carolina Benigno5, Elena Baldissera6, Elena Bartoloni-Bocci7, Fabio Basta8, Francesca Bellisai9, Alessandra Bortoluzzi10, Corrado Campochiaro6, Francesco Paolo Cantatore11, Roberto Caporali12, Angela Ceribelli13, Cecilia B Chighizola14, Paola Conigliaro15, Addolorata Corrado11, Maurizio Cutolo16, Salvatore D'Angelo17, Elena De Stefani10, Andrea Doria18, Maria Favaro18, Colomba Fischetti19, Rosario Foti20, Armando Gabrielli19, Elena Generali13, Roberto Gerli7, Maria Gerosa21, Maddalena Larosa18, Armin Maier22, Nazzarena Malavolta23, Marianna Meroni24, Pier Luigi Meroni25, Carlomaurizio Montecucco12, Marta Mosca26, Melissa Padovan10, Giuseppe Paolazzi27, Giulia Pazzola28, Susanna Peccatori27, Roberto Perricone15, Giorgio Pettiti29, Valentina Picerno17, Immacolata Prevete30, Véronique Ramoni12, Nicoletta Romeo29, Amelia Ruffatti18, Carlo Salvarani28, Gian Domenico Sebastiani30, Carlo Selmi13, Francesca Serale29, Luigi Sinigaglia31, Chiara Tani26, Marica Trevisani23, Marta Vadacca8, Eleonora Valentini7, Guido Valesini32, Elisa Visalli20, Ester Vivaldelli22, Lucia Zuliani19, Angela Tincani1.   

Abstract

OBJECTIVE: The reproductive choices of women affected by rheumatic diseases (RD) can be influenced by several factors, including the quality of physician-patient communication. We conducted a survey on reproductive issues aiming at exploring the unmet needs of women with RD during childbearing age.
METHODS: We administered 65 multiple-choice and 12 open-answer questions about pregnancy counselling, contraception, use of drugs during pregnancy and other women reproductive issues to 477 consecutive women with RD aged 18-55 years followed-up in 24 rheumatology centres in Italy. Analysis was restricted to 398 patients who received their diagnosis of RD before the age of 45. According to the RD diagnosis, patients were subdivided into 2 groups: connective tissue diseases (n = 249) and chronic arthritis (n = 149).
RESULTS: At the time of interview, women in both groups had a mean age of 40 years. Nearly one third of patients in each group declared not to have received any counselling about either pregnancy desire nor contraception. A smaller family size than desired was reported by nearly 37% of patients, because of concerns related to maternal disease in one fourth of the cases. A "Disease Knowledge Index" (DKI) was created to investigate the degree of patients' information about the implications of their RD on reproductive issues. Having received counselling was associated with higher DKI values and with a positive impact on family planning.
CONCLUSION: Italian women of childbearing age affected by RD reported several unmet needs in their knowledge about reproductive issues. Strategies are needed to implement and facilitate physician-patient communication.
Copyright © 2018. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Contraception; Counselling; Drugs; Pregnancy; Reproductive issues; Rheumatic diseases

Mesh:

Year:  2018        PMID: 30579917     DOI: 10.1016/j.jbspin.2018.12.002

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  10 in total

Review 1.  A comprehensive assessment of preconception health needs and interventions regarding women of childbearing age: a systematic review.

Authors:  Drieda Zaçe; Alessia Orfino; Anna Mariaviteritti; Valeria Versace; Walter Ricciardi; Maria Luisa DI Pietro
Journal:  J Prev Med Hyg       Date:  2022-04-26

2.  Reproductive health counseling and contraceptive use in Mexican women with rheumatic diseases: a cross-sectional study.

Authors:  Cassandra Michele Skinner-Taylor; Lorena Perez-Barbosa; Eugenio Salvador Barriga-Maldonado; Jesus Alberto Cardenas-de la Garza; Jazzia Emily Diaz-Angulo; Gabriel Figueroa-Parra; Janett Riega-Torres; Dionicio Angel Galarza-Delgado
Journal:  Rheumatol Int       Date:  2020-08-14       Impact factor: 2.631

3.  Effectiveness of reproductive health counseling of women with systemic lupus erythematosus: observational cross-sectional study at an academic lupus clinic.

Authors:  Luisa Brites; Stefanie Silva; Laura Andreoli; Luis Inês
Journal:  Rheumatol Int       Date:  2020-08-07       Impact factor: 2.631

Review 4.  Reproductive Issues and Pregnancy Implications in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Francesca Crisafulli; Liala Moschetti; Paolo Semeraro; Ana-Rita Cunha; Agna Neto; Andrea Lojacono; Francesca Ramazzotto; Cristina Zanardini; Sonia Zatti; Paolo Airò; Angela Tincani; Franco Franceschini; Laura Andreoli
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

5.  Views of Mexican outpatients with rheumatoid arthritis on sexual and reproductive health: A cross-sectional study.

Authors:  Loraine Ledón-LLanes; Irazú Contreras-Yáñez; Guillermo Guaracha-Basáñez; Salvador Saúl Valverde-Hernández; Anayanci González-Marín; Ángel de Jesús Ballinas-Sánchez; Marta Durand; Virginia Pascual-Ramos
Journal:  PLoS One       Date:  2021-01-28       Impact factor: 3.240

Review 6.  The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome.

Authors:  Cecilia Nalli; Jessica Galli; Daniele Lini; Angela Merlini; Silvia Piantoni; Maria Grazia Lazzaroni; Victoria Bitsadze; Jamilya Khizroeva; Sonia Zatti; Laura Andreoli; Elisa Fazzi; Franco Franceschini; Alexander Makatsariya; Yehuda Shoenfeld; Angela Tincani
Journal:  Front Pharmacol       Date:  2021-03-18       Impact factor: 5.810

7.  Impact of psoriatic disease on women aged 18 to 45: Results from a multinational survey across 11 European countries.

Authors:  Sandy R McBride; Maria C Fargnoli; Anne-Claire Fougerousse; Marta García Bustínduy; Louise Catton; Lerzan Senturk; Cécile Ecoffet; Jan Koren; Laura Andreoli; Laura C Coates; Alice Titialii
Journal:  Int J Womens Dermatol       Date:  2021-08-28

8.  Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists.

Authors:  Marta Olejárová; Želmíra Macejová; Spyridon Gkalpakiotis; Leona Procházková; Zoltán Tóth; Pavel Prágr
Journal:  Rheumatol Ther       Date:  2022-09-24

Review 9.  Impact of Psoriasis and Hidradenitis Suppurativa in Pregnancy, a Systematic Review.

Authors:  Maria-Angeles Ferrer-Alcala; Manuel Sánchez-Díaz; Salvador Arias-Santiago; Alejandro Molina-Leyva
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

10.  Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals.

Authors:  Laura Andreoli; Cecilia Nalli; Maria Grazia Lazzaroni; Chiara Carini; Francesca Dall'Ara; Rossella Reggia; Marília Rodrigues; Carolina Benigno; Elena Baldissera; Elena Bartoloni; Fabio Basta; Francesca Bellisai; Alessandra Bortoluzzi; Corrado Campochiaro; Francesco Paolo Cantatore; Roberto Caporali; Angela Ceribelli; Cecilia B Chighizola; Paola Conigliaro; Addolorata Corrado; Maurizio Cutolo; Salvatore D'Angelo; Elena De Stefani; Andrea Doria; Maria Favaro; Colomba Fischetti; Rosario Foti; Armando Gabrielli; Elena Generali; Roberto Gerli; Maria Gerosa; Maddalena Larosa; Armin Maier; Nazzarena Malavolta; Marianna Meroni; Pier Luigi Meroni; Carlomaurizio Montecucco; Marta Mosca; Melissa Padovan; Giuseppe Paolazzi; Giulia Pazzola; Susanna Peccatori; Roberto Perricone; Giorgio Pettiti; Valentina Picerno; Immacolata Prevete; Véronique Ramoni; Nicoletta Romeo; Amelia Ruffatti; Carlo Salvarani; Gian Domenico Sebastiani; Carlo Selmi; Francesca Serale; Luigi Sinigaglia; Chiara Tani; Marica Trevisani; Marta Vadacca; Eleonora Valentini; Guido Valesini; Elisa Visalli; Ester Vivaldelli; Lucia Zuliani; Angela Tincani
Journal:  Clin Rev Allergy Immunol       Date:  2021-03-16       Impact factor: 8.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.